Abstract:Infection of pregnant women by Zika virus (ZIKV) is associated with severe neurodevelopmental defects in newborns through poorly defined mechanisms. Here, we established a zebrafish in vivo model of ZIKV infection to circumvent limitations of existing mammalian models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain at early developmental stages. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including a reduced head area and neural progenitor cells (NPC) infection and depletion. Moreover, transcriptomic analyses of NPCs isolated from ZIKV-infected embryos revealed a distinct dysregulation of genes involved in survival and neuronal differentiation, including downregulation of the expression of the glutamate transporter vglut1 , resulting in an altered glutamatergic network in the brain. Mechanistically, ectopic expression of ZIKV protein NS4A in the larvae recapitulated the morphological defects observed in infected animals, identifying NS4A as a key determinant of neurovirulence and a promising antiviral target for developing therapies. Infections with Zika virus (ZIKV) constitute a major global public health concern worldwide. Indeed, infection of pregnant women can induce severe defects of the fetal brain and, eventually, microcephaly in the infant. Most importantly, no antiviral therapies or vaccines against ZIKV are currently available, as we poorly understand how the disease develops. Addressing these questions in mammalian models is highly challenging. Here, we report an alternative in vivo model of ZIKV infection based on zebrafish which circumvents limitations of existing models. Leveraging the unique tractability of this system, we gained unprecedented access to the ZIKV-infected brain during early developmental stages at the tissue, cell and molecular levels. The infection of zebrafish larvae with ZIKV phenocopied the disease in mammals including, a reduced head area and neural progenitor cells (NPC) infection and depletion. This correlated with a transcriptomic reprogramming of NPCs and alterations of the excitatory glutamatergic neuronal networks. Furthermore, we identified ZIKV NS4A as a key determinant of neuropathogenesis, supporting that this viral protein constitutes a promising antiviral target for developing therapies.

A Biomimetic Nanodecoy Traps Zika Virus to Prevent Viral Infection and Fetal Microcephaly Development.

A Single Injection of Human Neutralizing Antibody Protects Against Zika Virus Infection and Microcephaly in Developing Mouse Embryos.

Sevsrvg Selectively Delivers Antiviral Sirna to Fetus Brain, Inhibits ZIKV Infection and Mitigates ZIKV-induced Microcephaly in Mouse Model

Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication

Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through Direct Inactivation and Interferon Pathway.

Zika Virus Propagation and Release in Human Fetal Astrocytes Can Be Suppressed by Neutral Sphingomyelinase-2 Inhibitor GW4869

A Peptide-Based Viral Inactivator Inhibits Zika Virus Infection in Pregnant Mice and Fetuses.

A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model

Inhibition of Na+/K+ ATPase blocks Zika virus infection in mice

Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations

Novel Non-Segmented Negative-Sense Rna Virus-Based Vaccine Platforms For Zika Virus

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy

Discovery And Computational Analyses Of Novel Small Molecule Zika Virus Inhibitors

Disruption of Glial Cell Development by Zika Virus Contributes to Severe Microcephalic Newborn Mice

A safe replication-defective Zika virus vaccine protects mice from viral infection and vertical transmission

A Cell-Based Assay to Discover Inhibitors of Zika Virus RNA-dependent RNA Polymerase

A Mutation Identified in Neonatal Microcephaly Destabilizes Zika Virus NS1 Assembly in Vitro

Design, Synthesis, and Biological Evaluation of a Series of New Anthraquinone Derivatives As Anti-Zikv Agents.

Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids

A zebrafish-based in vivo model of Zika virus infection unveils alterations of the glutamatergic neuronal development and NS4A as a key viral determinant of neuropathogenesis

Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor